Back to Search
ELIZABETH HEXNER, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1366486250IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
MD419925(PA)
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 1999
Research & Publications (13)
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.
PMID 17984313·Blood·2008
7-preclinical
Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
PMID 17889349·Biol Blood Marrow Transplant·2007
7-preclinical
JAK2 V617F: implications for thrombosis in myeloproliferative diseases.
PMID 17934351·Curr Opin Hematol·2007
6-review
The role of T cells in hematopoietic stem cell engraftment.
PMID 16501826·ScientificWorldJournal·2006
6-review
RNA interference for treating haematological malignancies.
PMID 16318422·Expert Opin Biol Ther·2005
6-review
Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.
PMID 19643445·J Pediatr·2009
8-other
Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.
PMID 18819096·Am J Hematol·2008
5-case
CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
PMID 17709547·J Immunol·2007
7-preclinical
Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT).
PMID 17210175·Leuk Res·2007
6-review
Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells.
PMID 17227831·Blood·2007
7-preclinical
Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
PMID 15728519·J Immunol·2005
7-preclinical
Host-reactive CD8+ memory stem cells in graft-versus-host disease.
PMID 16288282·Nat Med·2005
4-observational
Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity.
PMID 14764532·Blood·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST, 15 PENN TOWER
PHILADELPHIA, PA 19104 - Phone
- (215) 662-3914
Quick Facts
- NPI
- 1366486250
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 13
Are you this provider?
Claim Your Profile